Drug · DIN 02405016
PERJETA
CONCENTRATE SOLUTION. 14 ML VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 8, 2013; first marketed May 8, 2013.
- Drug Identification Number (DIN)
- 02405016
- Company (DIN owner)
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Schedule
- Schedule D; Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Pertuzumab L01FD02
- Class
- Human
- Record last updated
- August 20, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PERTUZUMAB | 420 MG | 14 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 12, 2013: NOC 14288New Drug Submission (NDS)